Trexquant Investment LP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 82 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2021$263,000
+39.9%
43,768
+43.3%
0.02%
+50.0%
Q3 2018$188,000
-25.1%
30,539
-14.8%
0.01%
-50.0%
Q4 2017$251,000
+161.5%
35,863
+235.2%
0.03%
+86.7%
Q4 2016$96,00010,7000.02%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders